Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Consortium Service Management Group's tissue bonding device shows promise:

This article was originally published in Clinica

Executive Summary

A device that uses a low-heat delivery method to bond soft tissue has shown positive results in a clinical trial to assess its use in bowel reconstruction and repair surgery. The tissue bonding device, developed by US firm Consortium Service Management Group (CSMG), enabled surgeons to reliably bond the large intestine, and to do a haemostatic bond before anastomosing and bringing the intestine down, without using needles, sutural materials, staples or other foreign matter, says the Corpus Christi, Texas firm. The surgery was performed in Ukraine, where the device has marketing approval.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts